{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/653122757a90ab00122d80ab/6a7b7824f91cd396b39c8496?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"ADHD testing on a smartphone | Mini episode","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/653122757a90ab00122d80ab/1786475873359-b9e28389-9a43-4c31-b574-76ea782e9c05.jpeg?height=200","description":"<p>Is ADHD testing on a mobile or hand-held device the new thing in innovation and technology?</p><p><br></p><p>In this mini episode, ADHD experts discuss the evolution of objective ADHD assessment and how technology is slowly but surely moving from hardware to software to mobile technology. What could this mean for the future of ADHD care?</p><p><br></p><p>The trio discusses Qbtech’s work on QbMobile, including early findings around user acceptance and how mobile technology could make objective assessment more accessible.</p><p><br></p><p>The conversation also looks at the value of data from more than one million patients, and how large-scale, global datasets can help researchers identify new trends, inform clinicians, shape innovation, and contribute to conversations around healthcare policy</p><p><br></p><p><br></p><p>Watch the full episode: <a href=\"https://bit.ly/4qdakWe\" rel=\"noopener noreferrer\" target=\"_blank\">https://bit.ly/4qdakWe</a></p><p><br></p><p>Host: Danielle Vaeth (Senior Market Development Manager, Qbtech)</p><p>Guests: Ragini Sanyal (Head of Clinical Research) and Robert Nolen (Clinical Research Manager)</p><p><br></p><p>Topics covered:</p><p>–Why both clinical research and real-world evidence are essential for developing new ADHD technologies</p><p><br></p><p>–How clinician feedback shapes innovation and improves patient care</p><p><br></p><p>–The development of QbMobile and how smartphone technology could make ADHD testing more accessible</p><p><br></p><p>–What Qbtech has learned from a global database of more than 1 million ADHD assessments</p><p><br></p><p>–How remote ADHD treatment monitoring can improve patient access while supporting confident clinical decision-making</p><p><br></p><p>Who this is for:</p><p>Clinicians, pediatricians, psychiatrists, mental health professionals.</p>","author_name":"Qbtech"}